Rheumatoid arthritis: is it a coronary heart disease equivalent?

Stamatelopoulos, 2009, Atherosclerosis in rheumatoid arthritis versus diabetes: a comparative study, Arterioscler Throm Vasc Biol, 29, 1702, 10.1161/ATVBAHA.109.190108

Nurmohamed, 2009, Cardiovascular risk in rheumatoid arthritis, Autoimmun Rev, 8, 663, 10.1016/j.autrev.2009.02.015

John, 2009, Cardiovascular co-morbidity in rheumatoid arthritis, Best Pract Res Clin Rheumatol, 23, 71, 10.1016/j.berh.2008.11.007

Avina-Zubieta, 2008, Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies, Arthritis Rheum, 59, 1690, 10.1002/art.24092

Van Halm, 2009, Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation, Ann Rheum Dis, 68, 1395, 10.1136/ard.2008.094151

Peters, 2009, Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study, Arthritis Rheum, 61, 1571, 10.1002/art.24836

Ross, 1999, Atherosclerosis: an inflammatory disease, N Engl J Med, 340, 115, 10.1056/NEJM199901143400207

Panoulas, 2007, Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis, Rheumatology, 46, 1477, 10.1093/rheumatology/kem169

Toms, 2010, Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk?, Ann Rheum Dis, 69, 683, 10.1136/ard.2009.115717

Metsios, 2008, Rheumatoid arthritis, cardiovascular disease and physical exercise: a systematic review, Rheumatology, 47, 239, 10.1093/rheumatology/kem260

Panoulas, 2008, Hypertension in rheumatoid arthritis, Rheumatology, 47, 1286, 10.1093/rheumatology/ken159

Kitas, 2011, Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives, Ann Rheum Dis, 70, 8, 10.1136/ard.2010.142133

Stavropoulos-Kalinoglou, 2011, Obesity in rheumatoid arthritis, Rheumatology, 50, 450, 10.1093/rheumatology/keq266

Summers, 2010, Rheumatoid cachexia and cardiovascular disease, Nat Rev Rheumatol, 6, 445, 10.1038/nrrheum.2010.105

Metsios, 2007, Blockade of tumour necrosis factor alpha in rheumatoid arthritis: effects on components of rheumatoid cachexia, Rheumatology, 46, 1824, 10.1093/rheumatology/kem291

Stavropoulos-Kalinoglou, 2009, Associations of obesity with modifiable risk factors for the development of cardiovascular disease in patients with rheumatoid arthritis, Ann Rheum Dis, 68, 242, 10.1136/ard.2008.095596

Giles, 2010, Abdominal adiposity in rheumatoid arthritis: association with cardiometabolic risk factors and disease characteristics, Arthritis Rheum, 62, 3173, 10.1002/art.27629

Nurmohamed, 2009, Dyslipidaemia, statins and rheumatoid arthritis, Ann Rheum Dis, 68, 453, 10.1136/ard.2008.104497

Toms, 2010, Dyslipidaemia in rheumatoid arthritis: the role of inflammation, drugs, lifestyle and genetic factors, Curr Vasc Pharmacol, 8, 301, 10.2174/157016110791112269

Peters, 2010, The interplay between inflammation, lipids and cardiovascular risk in rheumatoid arthritis: why ratios may be better, Int J Clin Pract, 64, 1440, 10.1111/j.1742-1241.2009.02220.x

Toms, 2011, Are lipid ratios less susceptible to change with systemic inflammation than individual lipid components in patients with rheumatoid arthritis?, Angiology, 62, 167, 10.1177/0003319710373749

Dessein, 2006, Insulin resistance and impaired beta cell function in rheumatoid arthritis, Arthritis Rheum, 54, 2765, 10.1002/art.22053

Solomon, 2010, The risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis, Ann Rheum Dis, 69, 2114, 10.1136/ard.2009.125476

Daousi, 2006, Prevalence of obesity in type 2 diabetes in secondary care: association with cardiovascular risk factors, Postgrad Med J, 82, 280, 10.1136/pmj.2005.039032

Zeber, 2010, Cardiovascular risk in type 2 diabetes: attributable risk due to modifiable risk factors, Can Fam Physician, 56, e302

Casas, 2008, C-reactive protein and coronary heart disease: a critical review, J Intern Med, 264, 295, 10.1111/j.1365-2796.2008.02015.x

Van Leuven, 2007, Systemic inflammation as a risk factor for atherothrombosis, Rheumatology, 47, 3, 10.1093/rheumatology/kem202

Giles, 2009, Coronary arterial calcification in rheumatoid arthritis: comparison with the multiethnic study of atherosclerosis, Arthritis Res Ther, 11, R36, 10.1186/ar2641

Gabriel, 2010, Heart disease and rheumatoid arthritis: understanding the risks, Ann Rheum Dis, 69, i61, 10.1136/ard.2009.119404

Liang, 2009, Autoantibodies and risk of cardiovascular events, J Rheumatol, 36, 2462, 10.3899/jrheum.090188

Dessein, 2007, Independent role of cardiovascular risk factors as predictors of C-reactive protein concentrations in rheumatoid arthritis, J Rheumatol, 34, 681

Klarenbeek, 2010, Recent advances in the management of rheumatoid arthritis, BMJ, 341, c6942, 10.1136/bmj.c6942

Edwards, 2006, The treatment of coronary heart disease in patients with chronic kidney disease, QJM, 99, 723, 10.1093/qjmed/hcl101

Rossing, 2011, Need for better diabetes treatment for improved renal outcomes, Kidney Int, 79, S28, 10.1038/ki.2010.513

Daousis, 2010, Cardiovascular risk factors and not disease activity, severity or therapy associate with renal dysfunction in patients with rheumatoid arthritis, Ann Rheum Dis, 69, 517, 10.1136/ard.2008.105049

Panoulas, 2008, Serum uric acid is independently associated with hypertension in patients with rheumatoid arthritis, J Hum Hypertens, 22, 177, 10.1038/sj.jhh.1002298

Daousis, 2009, Uric acid is a strong independent predictor of renal dysfunction in patients with rheumatoid arthritis, Arthritis Res Ther, 11, R116, 10.1186/ar2775

Panoulas, 2007, Association of serum uric acid with cardiovascular disease in rheumatoid arthritis, Rheumatology, 46, 1466, 10.1093/rheumatology/kem159

Gonzalez, 2008, Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in nonrheumatoid arthritis patients?, Ann Rheum Dis, 67, 64, 10.1136/ard.2006.059980

Solomon, 2010, Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity, Ann Rheum Dis, 69, 1920, 10.1136/ard.2009.122226

Sandoo, 2010, The endothelium and its role in regulating vascular tone, Open Cardiovasc Med J, 4, 302, 10.2174/1874192401004010302

2005, Society, British Hypertension Society, Diabetes UK, HEART UK, Primary Care Cardiovascular Society, The Stroke Association. JBS 2: Joint British Societies guidelines on prevention of cardiovascular disease in clinical practice., Heart, 91, v1, 10.1136/hrt.2005.079988

John, 2007, Patient education on cardiovascular aspects of rheumatoid disease: an unmet need, Rheumatology, 46, 1513, 10.1093/rheumatology/kem176

John, 2009, ‘All singing from the same hymn sheet’: Healthcare professionals' perceptions of developing patient education material about the cardiovascular aspects of rheumatoid arthritis, Musculoskeletal Care, 7, 256, 10.1002/msc.157

Peters, 2010, EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis, Ann Rheum Dis, 68, 325, 10.1136/ard.2009.113696

Krishnan, 2004, Declines in mortality from acute myocardial infarction in successive incidence and birth cohorts of patients with rheumatoid arthritis, Circulation, 110, 1774, 10.1161/01.CIR.0000142864.83780.81

Popa, 2005, Influence of antitumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis, Ann Rheum Dis, 64, 303, 10.1136/ard.2004.023119

Make-Petaja, 2006, Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by antitumour necrosis factor-alpha therapy, Circulation, 114, 1185, 10.1161/CIRCULATIONAHA.105.601641

Greenberg, 2011, Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis., Ann Rheum Dis, 70, 576, 10.1136/ard.2010.129916

Dixon, 2007, Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to antitumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register, Arthritis Rheum, 56, 2905, 10.1002/art.22809

Westlake, 2011, Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review, Rheumatology, 50, 518, 10.1093/rheumatology/keq316

Hippisley-Cox, 2008, Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2, BMJ, 336, 1475, 10.1136/bmj.39609.449676.25

Genest, 2009, 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidaemia and prevention of cardiovascular disease in the adult: 2009 recommendations, Can J Cardiol, 25, 567, 10.1016/S0828-282X(09)70715-9

Peters, 2010, Statin treatment of rheumatoid arthritis: comment on the editorial by Ridker and Solomon, Arthritis Rheum, 62, 302, 10.1002/art.25054

McCarey, 2004, Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial., Lancet, 363, 2015, 10.1016/S0140-6736(04)16449-0

Van Sijl, 2011, Carotid intima media thickness in rheumatoid arthritis compared to control subjects: a meta-analysis., Semin Arthritis Rheum, 40, 389, 10.1016/j.semarthrit.2010.06.006

Gasparyan, 2010, The rationale for comparative studies of accelerated atherosclerosis in rheumatic diseases, Curr Vasc Pharmacol, 8, 437, 10.2174/157016110791330852